FTO (freedom to operate) in the pharmaceutical industry

FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to pe...

Descripción completa

Detalles Bibliográficos
Otros Autores: Nonaka, Hirotaka, author (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Baden-Baden, Germany : Nomos Verlagsgesellschaft mbH & Co. KG 2018
2018.
Edición:First edition
Colección:MIPLC studies ; Volume 34.
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009432215906719
Descripción
Sumario:FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed.
Descripción Física:1 online resource (64 pages)
Bibliografía:Includes bibliographical references.
ISBN:9783845294018